Intended for healthcare professionals

  1. No consent should be...
  2. No consent should be needed for using leftover body material for scientific purposesForAgainst
Education And Debate For and against

No consent should be needed for using leftover body material for scientific purposesForAgainst

BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7365.648 (Published 21 September 2002) Cite this as: BMJ 2002;325:648

Related articles

See more

Cited by...

  • The lysosomal V-ATPase B1 subunit in proximal tubule is linked to nephropathic cystinosis
  • "As Long as You Ask": A Qualitative Study of Biobanking Consent--Oncology Patients and Health Care Professionals Attitudes, Motivations, and Experiences--the B-PPAE Study
  • Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases
  • Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification
  • Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma
  • RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3
  • Validity of whole slide images for scoring HER2 chromogenic in situ hybridisation in breast cancer
  • Generation of an inducible colon-specific Cre enzyme mouse line for colon cancer research
  • Evidence of broad-based family support for the use of archival childhood tumour samples in future research
  • The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study
  • Targeting DDX3 with a small molecule inhibitor for lung cancer therapy
  • Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray study
  • Turning residual human biological materials into research collections: playing with consent
  • Methylation profiles of endometrioid and serous endometrial cancers
  • Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers
  • Opt-out plus, the patients' choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment
  • Methylation of the TWIST1 Promoter, TWIST1 mRNA Levels, and Immunohistochemical Expression of TWIST1 in Breast Cancer
  • mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy?
  • Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis
  • Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries
  • Progressive derailment of cell cycle regulators in endometrial carcinogenesis
  • Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data
  • Ethical and legal issues in research involving human subjects: do you want a piece of me?
  • Obtaining explicit consent for the use of archival tissue samples: practical issues
  • A study of public opinion on the use of tissue samples from living subjects for clinical research
  • Consent to using human tissue
  • Cadaveric tissue donation: a pathologist's perspective
Back to top